Christopher Hartley, MD

Christopher Hartley, MD

Christopher Hartley, MD

Medical School: Wake Forest School of Medicine
Winston-Salem, NC
Year of Graduation:

I was born in Birmingham, Alabama, raised in southwestern Pennsylvania, attended boarding school in eastern Maryland followed by Lake Forest College in Lake Forest, Illinois. I completed medical school at Wake Forest University in Winston-Salem, North Carolina. For the first two years of AP/CP residency, I was in Lebanon, New Hampshire at Dartmouth-Hitchcock Medical Center. I decided to transfer from New Hampshire for Wisconsin for personal reasons to continue my training at the Medical College of Wisconsin (MCW). I am lucky to maintain close contact with friends and collaboration and correspondence with advisors in New Hampshire. I am also fortunate that I have found new friends and advisors in the residents and attendings at MCW.

Milwaukee in the summer seems like a never-ending sequence of festivals, music events, boat cruises, and of course plenty of beer and cheese tasting. Other opportunities I’ve explored are walking and biking on scenic paths along Lake Michigan, and taking the 1 and a half hour train ride to Chicago. The winter seems to be a retreat indoors for many of the activities enjoyed outdoors in the summer with outdoor activities dependent on snow fall and cold tolerance. Having lived in cities in the south, the mid-atlantic, the mid-west, and the north-east, I have noticed Milwaukee is unique for its low cost of living, number of cultural opportunities – especially in music, and quality of restaurants.
To end on an academic note, I have found MCW to be incredibly supportive of research at every level of the department.

Peer Reviewed Publications:

1. Hartley CP, Steinmetz HB, Memoli VA, Tafe LJ. Small cell neuroendocrine carcinomas of the lung do not harbor high-risk human papillomavirus (HR-HPV).Human Pathology. Published 9 Jan 2015.

2. Fearing BV, Hartley CP, Dayton OL, Sherwood G, AbouShwareb T, Van Dyke ME. Treatment of a Spinal Cord Hemitransection Injury with Keratin Biomaterial Hydrogel Elicits Recovery and Tissue Repair. ISRN Biomaterials. Volume 2014, 9 pages: Published 23 March 2014. http://dx.doi.org/10.1155/2014/426047

Platform Presentations:

1. Hartley CP, Rowan D, Carrillo L, Oshima K, Hagen C. Who Are You Calling Indeterminate? Classification of Colon Biopsies with 6 or Fewer Apoptotic Bodies Predicts Decision to Treat in the Evaluation of Gastrointestinal Graft Versus Host Disease. Accepted for platform presentation: 104th United States and Canadian Academy of Pathology Annual Meeting, March 21-27, 2015, Boston, MA. Mod Pathol vol 28, supplement 2, 2015 Feb: 164A (645).

2. Carrillo L, Hartley CP, Rowan D, Hagen C. Gastrointestinal Graft Versus Host Disease in Autologous Versus Allogeneic Transplant Patients: Earlier Onset and More Apoptosis. Accepted for platform presentation: 104th United States and Canadian Academy of Pathology Annual Meeting, March 21-27, 2015, Boston, MA. Mod Pathol vol 28, supplement 2, 2015 Feb: 151A (594).

Poster Presentations:

1. Rowan D, Hartley CP, Carrillo-Polanco L, Hagen C. Indeterminate for GVHD: Clinical and endoscopic correlation with a new equivocal category of gastrointestinal GVHD identifies patients that may be spared increased immunosuppression. Poster presentation: Digestive Disease Week 2015, May 16-19, 2015, Washington, DC.

2. Hartley CP, Hintzke M, Vaughan J, Hosking P, Harrington A, Kroft S, Olteanu H. CD30 Expression in Post-Transplant Lymphoproliferative Disorders. Accepted for poster presentation: 104th United States and Canadian Academy of Pathology Annual Meeting, March 21-27, 2015, Boston, MA. Mod Pathol vol 28, supplement 2, 2015 Feb: 349A (1396).

3. Hembrough T, Liao W, Hartley CP, Thyparambil S, An E, Burrows J, Tafe LJ. Quantification of ALK from Non-Small Cell Lung Cancer (NSCLC) FFPE Tissue by Targeted Mass Spectrometry. Poster presentation: 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology, Oct 30 – Nov 1, 2014. Chicago, IL.

4. Hartley CP, Peterson JD, de Abreu FB, Gutmann EJ, Padmanabhan V, Marotti JD, Tafe LJ, Wells WA, Tsongalis GJ, Amos CI, Liu X. Adequacy of Formalin-fixed Paraffin-embedded (FFPE) Cytology Specimens for Next-generation Sequencing (NGS) with the Ion Torrent PGM: a 10 Month Experience at a Tertiary Care Center. Poster presentation: College of American Pathologists Annual Meeting, September 7-10, 2014, Chicago, IL.

5. Putra J, De Abreu FB, Hartley CP, Burchard PR, Tsongalis GJ, Suriawinata AA. Underexpression of MicroRNA-370 is Associated with Nonalcoholic Steatohepatitis. Poster presentation: Digestive Disease Week 2014, May 4-6, 2014, Chicago, IL. Gastroenterology 2014; 146: 956-967.

6. Putra J, Hartley CP, Pierce KJ, Chang CH, Toor A, Dickson RC, Suriawinata AA. The Role of Serial Liver Biopsy in Chronic Liver Disease: a Single-institution study. Poster presentation: Digestive Disease Week 2014, May 4-6, 2014, Chicago, IL. Gastroenterology 2014; 146: 737-738.

7. Hartley CP, Liao W, Burrows J, Hembrough T, Tafe LJ. Quantification of ALK from Formalin-Fixed Paraffin-Embedded Non-small Cell Lung Cancer (NSCLC) Tissue by Mass Spectrometry. Poster presentation: 103rd United States and Canadian Academy of Pathology Annual Meeting, March 1-7, 2014, San Diego, CA. Mod Pathol vol 27, supplement 2, 2014 Feb: 479A (1969).

8. Hartley CP, Steinmetz HB, Memoli VA, Tafe LJ. Detection of High-Risk Human Papillomavirus (HR-HPV) Genotypes and P16 Up-regulation in Small Cell Lung Cancer (SCLC). Poster presentation: 103rd United States and Canadian Academy of Pathology Annual Meeting, March 1-7, 2014, San Diego, CA. Mod Pathol vol 27, supplement 2, 2014 Feb: 479A (1970).

9. Liao W, Thyparambil S, An E, Hartley CP, Ma P, Rodriguez J, Wistuba I, Burrows J, Hembrough T, Tafe LJ. Multiplexed Mass Spectrometry-based Assay to Quantify Translocation Markers from Non-small Cell Lung Cancer (NSCLC) FFPE Tissue. Clin Cancer Res January 15, 2014 20:B09 Poster presentation: International Association for the Study of Lung Cancer 2014 annual meeting.

10. Fearing BV, Hartley CP, Dayton OL, AbouShwareb T, Van Dyke ME. Treatment of a Spinal Cord Hemitransection Injury with a Keratin Biomaterial. Poster Presentation: Tissue Engineering and Regenerative Medicine International Society (TERMIS)-NA Conference 2010, Orlando, FL.

11. Fearing BV, Hartley CP, Dayton OL, AbouShwareb T, Van Dyke ME. Treatment of Spinal Cord Injury with Keratin Biomaterial Improves Survival and Recovery in Rats. Poster presentation: Biomedical Engineering Society (BMES) Annual Meeting 2010, Austin, TX.

12. Hartley CP, Dayton OL, Fearing BV, AbouShwareb T, Van Dyke ME. Survival and Functional Recovery in Spinal Cord Hemitransection Injury in Rats Treated with Keratin Biomaterial Hydrogel. Poster presentation: Wake Forest University School of Medicine Medical Student Research Day, October 2009, Winston-Salem, NC.